CinCor Pharma, Inc. CINC
Trading inactive
| Déclarant | Citoyenneté ou lieu d'organisation | Pouvoir de vote unique | Pouvoir de vote partagé | Pouvoir de disposition unique | Pouvoir de disposition partagé | Montant en propriété effective | Pourcentage détenu | Date d'achat |
|---|---|---|---|---|---|---|---|---|
| Robert Adelman | United States of America | 0 | 1862256 | 0 | 1862256 | 1862256 | 4.9 % | 26/09/2022 |
| Corey Goodman | United States of America | 0 | 1862256 | 0 | 1862256 | 1862256 | 4.9 % | 26/09/2022 |
| venBio Global Strategic Fund III, L.P. | Cayman Islands | 0 | 1862256 | 0 | 1862256 | 1862256 | 4.9 % | 26/09/2022 |
| venBio Global Strategic GP III, L.P. | Cayman Islands | 0 | 1862256 | 0 | 1862256 | 1862256 | 4.9 % | 26/09/2022 |
| venBio Global Strategic GP III, Ltd. | Cayman Islands | 0 | 1862256 | 0 | 1862256 | 1862256 | 4.9 % | 26/09/2022 |
| Robert Adelman | United States of America | 0 | 1862256 | 0 | 1862256 | 1862256 | 4.9 % | 26/09/2022 |
| Corey Goodman | United States of America | 0 | 1862256 | 0 | 1862256 | 1862256 | 4.9 % | 26/09/2022 |
| venBio Global Strategic Fund III, L.P. | Cayman Islands | 0 | 1862256 | 0 | 1862256 | 1862256 | 4.9 % | 26/09/2022 |
| venBio Global Strategic GP III, L.P. | Cayman Islands | 0 | 1862256 | 0 | 1862256 | 1862256 | 4.9 % | 26/09/2022 |
| venBio Global Strategic GP III, Ltd. | Cayman Islands | 0 | 1862256 | 0 | 1862256 | 1862256 | 4.9 % | 26/09/2022 |
| Adage Capital Partners, L.P. | Delaware | 0 | 2140546 | 0 | 2140546 | 2140546 | 5.86 % | 21/01/2022 |
| Phillip Gross | United States | 0 | 2140546 | 0 | 2140546 | 2140546 | 5.86 % | 21/01/2022 |
| Robert Atchinson | United States | 0 | 2140546 | 0 | 2140546 | 2140546 | 5.86 % | 21/01/2022 |
| Adage Capital Advisors, L.L.C. | Delaware | 0 | 2140546 | 0 | 2140546 | 2140546 | 5.86 % | 21/01/2022 |
| Adage Capital Partners GP, L.L.C. | Delaware | 0 | 2140546 | 0 | 2140546 | 2140546 | 5.86 % | 21/01/2022 |
| Adage Capital Partners, L.P. | Delaware | 0 | 2140546 | 0 | 2140546 | 2140546 | 5.86 % | 21/01/2022 |
| Phillip Gross | United States | 0 | 2140546 | 0 | 2140546 | 2140546 | 5.86 % | 21/01/2022 |
| Robert Atchinson | United States | 0 | 2140546 | 0 | 2140546 | 2140546 | 5.86 % | 21/01/2022 |
| Adage Capital Advisors, L.L.C. | Delaware | 0 | 2140546 | 0 | 2140546 | 2140546 | 5.86 % | 21/01/2022 |
| Adage Capital Partners GP, L.L.C. | Delaware | 0 | 2140546 | 0 | 2140546 | 2140546 | 5.86 % | 21/01/2022 |
| 5AM Opportunities I, L.P. | Delaware, United States of America | 0 | 496323 | 0 | 496323 | 496323 | 1.4 % | 21/01/2022 |
| 5AM Ventures VI, L.P. | Delaware, United States of America | 0 | 3841323 | 0 | 3841323 | 3841323 | 10.5 % | 21/01/2022 |
| 5AM Partners VI, LLC | Delaware, United States of America | 0 | 3841323 | 0 | 3841323 | 3841323 | 10.5 % | 21/01/2022 |
| 5AM Opportunities I | Delaware, United States of America | 0 | 496323 | 0 | 496323 | 496323 | 1.4 % | 21/01/2022 |
| Andrew J. Schwab | United States of America | 0 | 4337646 | 0 | 4337646 | 4337646 | 11.9 % | 21/01/2022 |
| Dr. Kush Parmar | United States of America | 0 | 4337646 | 0 | 4337646 | 4337646 | 11.9 % | 21/01/2022 |
| Andrew J. Schwab | United States of America | 0 | 4337646 | 0 | 4337646 | 4337646 | 11.9 % | 21/01/2022 |
| Dr. Kush Parmar | United States of America | 0 | 4337646 | 0 | 4337646 | 4337646 | 11.9 % | 21/01/2022 |
| 5AM Ventures VI, L.P. | Delaware, United States of America | 0 | 3841323 | 0 | 3841323 | 3841323 | 10.5 % | 21/01/2022 |
| 5AM Partners VI, LLC | Delaware, United States of America | 0 | 3841323 | 0 | 3841323 | 3841323 | 10.5 % | 21/01/2022 |
| 5AM Opportunities I, L.P. | Delaware, United States of America | 0 | 496323 | 0 | 496323 | 496323 | 1.4 % | 21/01/2022 |
| 5AM Opportunities I | Delaware, United States of America | 0 | 496323 | 0 | 496323 | 496323 | 1.4 % | 21/01/2022 |
| venBio Global Strategic GP III, L.P. | Cayman Islands | 0 | 1980706 | 0 | 1980706 | 1980706 | 5.6 % | 11/01/2022 |
| venBio Global Strategic Fund III, L.P. | Cayman Islands | 0 | 1980706 | 0 | 1980706 | 1980706 | 5.6 % | 11/01/2022 |
| Aaron Royston | United States of America | 0 | 1980706 | 0 | 1980706 | 1980706 | 5.6 % | 11/01/2022 |
| Corey Goodman | United States of America | 0 | 1980706 | 0 | 1980706 | 1980706 | 5.6 % | 11/01/2022 |
| Robert Adelman | United States of America | 0 | 1980706 | 0 | 1980706 | 1980706 | 5.6 % | 11/01/2022 |
| venBio Global Strategic GP III, Ltd. | Cayman Islands | 0 | 1980706 | 0 | 1980706 | 1980706 | 5.6 % | 11/01/2022 |
| venBio Global Strategic GP III, L.P. | Cayman Islands | 0 | 1980706 | 0 | 1980706 | 1980706 | 5.6 % | 11/01/2022 |
| venBio Global Strategic Fund III, L.P. | Cayman Islands | 0 | 1980706 | 0 | 1980706 | 1980706 | 5.6 % | 11/01/2022 |
| Aaron Royston | United States of America | 0 | 1980706 | 0 | 1980706 | 1980706 | 5.6 % | 11/01/2022 |
| Corey Goodman | United States of America | 0 | 1980706 | 0 | 1980706 | 1980706 | 5.6 % | 11/01/2022 |
| Robert Adelman | United States of America | 0 | 1980706 | 0 | 1980706 | 1980706 | 5.6 % | 11/01/2022 |
| venBio Global Strategic GP III, Ltd. | Cayman Islands | 0 | 1980706 | 0 | 1980706 | 1980706 | 5.6 % | 11/01/2022 |
| CinRx Pharma, LLC | Ohio | 2865397 | 0 | 3630102 | 0 | 3630102 | 7.8 % | 11/01/2022 |